Released Oct 31, 2016, after the close
10-Q filed Oct 31, 2016, 31 days after period end · 0001564590-16-026578
Q3 2016 · 10-Q
Revenue$98.50M$98.50M −2.6% vs Q3 2015−5.4% vs Q2 2016
Net Income$9.90M$9.90M N/M vs Q3 2015N/M vs Q2 2016
EPS Diluted$0.54$0.54 N/M vs Q3 2015N/M vs Q2 2016
Gross Profit$78,617,000+1.7%
Operating Income$9,271,000+124.0%
Operating Cash Flowderived$17,023,000−3.2%
Free Cash Flowderived$13,689,000+35.6%
Margins · derived
Gross margin79.8%+3.4 pt vs Q3 2015
Operating margin9.4%+5.3 pt vs Q3 2015
Net margin10.0%+11.4 pt vs Q3 2015
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | $98.50M | $101.15M | $100.99M | $91.81M |
| Net Income | $9.90M | -$1.37M | $452.00K | -$18.84M |
| EPS Diluted | $0.54 | -$0.07 | $0.02 | -$1.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR